Ajanta Pharma Limited

Ajanta Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 3347.5, up 1.94% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.12% on the day, quoting at 22572.85. The Sensex is at 73083.53, down 0.06%. Ajanta Pharma Ltd has dropped around 5.04% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has dropped around 4.09% in last one month and is currently quoting at 25329.45, up 1.34% on the day. The volume in the stock stood at 35018 shares today, compared to the daily average of 98988 shares in last one month.The PE of the stock is 40.7 based on TTM earnings ending June 26.

Ajanta Pharma Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026.

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 3368.2, down 0.92% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.81% on the day, quoting at 22544.1. The Sensex is at 72458.04, up 0.74%.Ajanta Pharma Ltd has eased around 4.05% in last one month.Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has eased around 1.02% in last one month and is currently quoting at 26078.85, down 0.6% on the day. The volume in the stock stood at 18894 shares today, compared to the daily average of 1.08 lakh shares in last one month.The PE of the stock is 42.16 based on TTM earnings ending June 26.

Ajanta Pharma Limited submitted a certificate to the BSE Limited and National Stock Exchange of India under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by MUFG Intime India Private Limited, formerly Link Intime India Private Limited, the company’s registrar and share transfer agent.

Aayush Agrawal, trustee of Aayush Agrawal Trust, disclosed the creation of a pledge on 4,60,000 equity shares of Ajanta Pharma Limited on September 28, 2026, for the purpose of issuing non-convertible debentures. The pledge represents 0.37% of the company's total share capital, according to a filing with the BSE and National Stock Exchange of India.

Aayush Agrawal, trustee of Aayush Agrawal Trust, disclosed the release of a pledge on 98,185 equity shares of Ajanta Pharma Limited, citing loan repayment as the reason. The release, along with other releases by various entities including Yogesh M Agrawal, Rajesh M Agrawal, Ravi P Agrawal, and Aditya Birla Capital Ltd, occurred between September 21 and September 23, 2026.

Ajanta Pharma Limited will close its trading window for securities transactions from October 1, 2026, until 48 hours after the announcement of its financial results for the second quarter and half year ended September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Ajanta Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 3582.5, down 1.57% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.32% on the day, quoting at 24173.35. The Sensex is at 77284.45, down 0.33%.Ajanta Pharma Ltd has gained around 5.8% in last one month.Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has increased around 1.52% in last one month and is currently quoting at 26359.75, down 0.07% on the day. The volume in the stock stood at 30301 shares today, compared to the daily average of 1.1 lakh shares in last one month.The PE of the stock is 45.16 based on TTM earnings ending June 26.

Ravi Agrawal, trustee of Ravi Agrawal Trust, released a pledge on 6,910 equity shares of Ajanta Pharma Limited on August 14, 2026, citing business financing as the reason, according to a regulatory filing with the BSE and National Stock Exchange. Aditya Birla Capital Limited was the lender, and Barclays Securities (India) Private Limited acted as the depositary participant.

Ravi Agrawal, a promoter of Ajanta Pharma Limited, has released a pledge on 54,796 equity shares of the company, citing "Excess Pledge" as the reason. The release involved multiple transactions between August 6 and August 12, 2026, with lenders including Deutsche Investments India Pvt Ltd, Bajaj Finance Limited, INFINA FINANCE LIMITED, and Tata Capital Limited, facilitated through Barclays Securities (India) Private Limited.